Aguair LLC. Develops Complete Surface and Air Biosecurity Solution to Combat COVID-19 through SaniCart™ and ClensAir™ Technologies
MARIETTA, Ga.--(BUSINESS WIRE)--Mar 6, 2020--
AGUAIR LLC., a Georgia based manufacturing and engineering company, announces a complete surface and air sanitation package through its SaniCart™ micro-fog sanitation and ClensAir™ air purifier technologies, offering a potential game changer in controlling the spread of coronaviruses. Unlike most technologies that target only air or surface sanitation, Aguair’s unique and complete sanitation package targets droplet, surface, and airborne viral transmission to prevent the spread of COVID-19, allowing public and private institutions to protect customers, employees, and beneficiaries from this growing outbreak.
SaniCart™ and ClensAir™ technologies were initially designed for postharvest preservation. However, these technologies can be extended to all indoor environments including schools, waiting rooms, airports, hotels, athletic facilities, public restrooms, offices, ambulances, cruise ships, public transportation, and airplanes.
SaniCart™ is a mobile, fogging sanitization system, used to protect against surface and airborne viral, bacterial, and mold contamination. The SaniCart™ technological breakthrough involves a patented micro-fog nozzle, which humidifies the entire room with any disinfectant. Compared to hand-held or aerosol sprayers, this fine disinfecting fog efficiently covers the complete indoor environment and settles on all surfaces and hard-to-reach areas without residues. Its simplistic design allows the user to move from room to room and set an automated sanitization protocol to deliver a disinfectant of choice, including peracetic acid, hydrogen peroxide, chlorine dioxide, citric acid, or any other EPA-approved viral biocide. SaniCart™ technology helps reduce human error and minimize user exposure to sanitizing chemicals and pathogens, while also saving time, money, and labor.
Aguair’s patent-pending air purifier, ClensAir™, is a unique 6-stage technology that has been tested in-vitro by two independent, internationally acclaimed research laboratories to remove 99.90% of a viral simulant for COVID-19, Influenza, SARS and MERS, 99.97% of MRSA and hospital-acquired nosocomial bacteria, and 99.51% of Anthrax causing bacteria. ClensAir™uses a proprietary multi-stage technology to continuously ‘annihilate’ airborne viruses and bacteria, permanently destroying them and reducing the total pathogen load in the environment. In contrast, traditional air purifiers that use HEPA filters trap pathogens, allowing viruses, bacteria, and mold spores to remain viable within the system, posing a threat for re-exposure.
Aguair LLC. is a leading engineering and manufacturing company that provides biosecurity and sanitation solutions, including drinking water treatment systems.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200306005084/en/
CONTACT: Nadya Merchant, PhD
KEYWORD: GEORGIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: MEDICAL SUPPLIES MANUFACTURING MANAGED CARE HEALTH GENERAL HEALTH SPECIALTY INFECTIOUS DISEASES RETAIL HOSPITALS HOME GOODS CHEMICALS/PLASTICS
SOURCE: AGUAIR LLC.
Copyright Business Wire 2020.
PUB: 03/06/2020 06:07 AM/DISC: 03/06/2020 06:07 AM